Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...

Jim Cramer threw a curveball on Pfizer’s stock during a recent caller interaction, suggesting a wait-and-see approach ...

Croda International Plc ( OTCPK:COIHF) Q2 2025 Earnings Conference Call July 29, 2025 4:00 AM ET David Bishop - Director of Investor Relations Stephen Edward Foots - Group Chief Executive & Executive ...

Merck (MRK) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2.28 per share a year ago. These figures are ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...

Greg Duncan's love of dairy developed while studying agricultural science at Charles Sturt University, when he took on a ...

Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Stocks With Huge Catalysts on the Horizon. On May 13, Advanced Micro ...

Pinnacle Associates Ltd. increased its Danaher holdings by 5.3%, now owning shares worth $5.42 million. Institutional ...